WPD Pharmaceuticals (XCNQ:WBIO) Current Deferred Revenue : C$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

WPD Pharmaceuticals's current deferred revenue for the quarter that ended in Dec. 2023 was C$0.00 Mil.

WPD Pharmaceuticals Current Deferred Revenue Historical Data

The historical data trend for WPD Pharmaceuticals's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Current Deferred Revenue Chart

WPD Pharmaceuticals Annual Data

Trend

Jan13

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

0.63

WPD Pharmaceuticals Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

WPD Pharmaceuticals Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals (XCNQ:WBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

750 West Pender Street, Suite 401, Vancouver, BC, CAN, V6C 2T7

Website

https://www.wpdpharmaceuticals.com

WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.

WPD Pharmaceuticals (XCNQ:WBIO) Headlines

No Headlines